Metavista3D Files New Patent Application for Automotive Display Technology 
SuperQ Secures Strategic European Foothold via Landmark Partnership with Fraunhofer Institute for Industrial Mathematics ITWM; Positions for Global Dominance in Hybrid Quantum 
Paul Advisory & Legal Group Introduces Equity Stripping and Offshore Trusts as Key Asset Protection Strategies, Changing the Economics of Litigation 
Genviral Releases OpenClaw Skill to Automate Social Media Content Across Six Platforms 
Clear Ads Launches AI Search Optimization as 93% of AI Mode Queries Skip Websites ROBO Global Launches Venture Fund Focused on Emerging Technology
Fund designed to provide direct access to the technological innovation in the private market DALLAS–(BUSINESS…
Amshore Renewable Energy Announces New Executive Appointments
Chief Administrative Officer Cas Purdy and Controller Leo Anzaldua Lead Administration and Finance at Renewable…
IronNet Enhances Collective Defense Platform
New capabilities designed to reduce false positives through automated alert correlation and triage, enable malicious…
OncoMyx Appoints Robert Williamson Chief Business and Chief Financial Officer
PHOENIX–(BUSINESS WIRE)–#biotech—OncoMyx Therapeutics, a privately-held oncolytic virus immunotherapy company, today announced the appointment of Robert…
Flux Power to Attend the 34th Annual ROTH Conference March 13-15, 2022
VISTA, Calif.–(BUSINESS WIRE)–Flux Power Holdings, Inc. (NASDAQ: FLUX), a developer of advanced lithium-ion energy storage…
Dremio Announces Open and Forever-Free Lakehouse Platform, Dremio Cloud, on AWS
New platform enables a groundbreaking Git-like experience for data engineers SANTA CLARA, Calif.–(BUSINESS WIRE)–Dremio, the…
Principal Financial Group Announces 2022 Outlook
DES MOINES, Iowa–(BUSINESS WIRE)–Principal Financial Group® (Nasdaq: PFG) announced its 2022 financial guidance today, including…
Jim Choumas of Hammerspace Named a 2022 CRN Channel Chief
Powering the Future of Global Data Environments with Partner-Led Success SAN MATEO, Calif.–(BUSINESS WIRE)–#data—Hammerspace, the…
Blue.cloud Receives Growth Investment and $100M+ Valuation From Hudson Hill Capital
In 2021, Blue.cloud experienced 185% YoY revenue growth and nearly tripled its headcount Their deep…
Kaleyra: “COVID-19 has Accelerated the Digitalization of Communications in the Banking Industry”
Leveraging cross-channel automation to better understand customers and their need for 24/7 interaction, wherever they…
ProMIS Neurosciences’ PMN310 antibody demonstrates significant cognitive benefit in a mouse model of Alzheimer’s disease
Transgenic mouse model reflects latest scientific understanding of disease – toxic oligomers of amyloid create…
Evelo Biosciences to Participate in Cowen 42nd Annual Health Care Conference
CAMBRIDGE, Mass., March 02, 2022 (GLOBE NEWSWIRE) — Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage…
IsoPlexis Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Revenue Outlook for 2022
2021 revenue increased 66% over prior year period BRANFORD, Conn., March 02, 2022 (GLOBE NEWSWIRE)…
Manitoba Harvest to Unveil New Superfood Lineup
Pioneers in Hemp and Natural Foods Will Present ‘THE POWER OF HEMP’ and Introduce New…
Intercept Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results, Issues 2022 Financial Guidance and Provides Business Update
Worldwide Ocaliva® net sales of $92.4 million and $363.5 million for the fourth quarter and…
Instil Bio to Present at the Cowen 42nd Annual Health Care Conference
DALLAS, March 02, 2022 (GLOBE NEWSWIRE) — Instil Bio, Inc. (“Instil”) (Nasdaq: TIL), a clinical-stage…
Akari Therapeutics Appoints Rachelle Jacques as President and Chief Executive Officer
Industry veteran brings extensive experience in the development and commercialization of advanced biological therapies, including in the…
COMPASS Pathways to participate in Cowen and Roth investor conferences
LONDON, March 02, 2022 (GLOBE NEWSWIRE) — COMPASS Pathways plc (Nasdaq: CMPS), a mental health…
ALX Oncology Announces First Patient Dosed in ASPEN-06, a Phase 2/3 Study of Evorpacept for the Treatment of Patients with Advanced Gastric or Gastroesophageal Junction Cancer
Phase 2/3 study initiated in collaboration with Eli Lilly and Company SOUTH SAN FRANCISCO, Calif.,…
Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
WALTHAM, Mass., March 02, 2022 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical…